Institutional & Family Asset Management, LLC Fate Therapeutics Inc Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$9.86 - $23.83 $78 - $190	8 Added 160.0%	13 $0
Q1 2022 May 11, 2022	BUY	$29.67 - $60.28 $148 - $301	5 New	5 $0
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $239 - $321	-5 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$59.27 - $95.73 $237 - $382	-4 Reduced 44.44%	5 $0
Q1 2021 May 06, 2021	SELL	$72.16 - $117.4 $360 - $587	-5 Reduced 35.71%	9 $1,000
Q4 2020 Feb 03, 2021	BUY	$38.09 - $100.95 $533 - $1,413	14 New	14 $1,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

Redmile Group, LLC San Francisco, CA

13.2M
Shares

$35.3 Million
3.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$27.9 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$27.1 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.57M
Shares

$14.9 Million
0.72% of portfolio
State Street Corp Boston, MA

5.25M
Shares

$14.1 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $260M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account